Current investigations into retatritide peptide highlight promising potential for addressing excess body and type 2 diabetes. The molecule, a dual stimulator of GLP-1 receptor and GIP receptor, seems to provide improved weight loss and glucose regulation versus existing treatments. Ongoing research efforts are necessary to completely assess its saf